Category : Press Releases Archives - PridCor Therapeutics

PridCor Therapeutics Advances SHIELD Study Through Dual.

TUSCALOOSA, Ala., Jan. 06, 2026 (GLOBE NEWSWIRE) — PridCor Therapeutics, a clinical-stage biopharmaceutical company developing antiviral.

Read More

PridCor Therapeutics Principal Investigator Dr. David Putrino.

TUSCALOOSA, Ala., Sept. 23, 2025 (GLOBE NEWSWIRE) — PridCor Therapeutics today announced that Dr. David.

Read More

PridCor Therapeutics Reports Positive Long COVID Case.

September 04, 2025 10:32 ET | Source: GlobalNewsWire-New Preprint: PridCor Therapeutics LLC has released a pre-print detailing a.

Read More